Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
Lung cancer statistics, 2023
2024 Standout
Single-cell and spatial transcriptomics analysis of non-small cell lung cancer
2024 Standout
Works of P Postmus being referenced
Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.
1997
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| P Postmus | 71 | 358 | 264 | 259 | 5 | 383 | |
| Ali H. Ibrahim | 65 | 275 | 276 | 156 | 6 | 427 | |
| S. Veach | 113 | 269 | 102 | 212 | 5 | 340 | |
| Deshui Jia | 82 | 198 | 239 | 100 | 7 | 369 | |
| Colin T. Dunn | 40 | 181 | 182 | 115 | 7 | 340 | |
| Nils P. Boye | 174 | 336 | 135 | 293 | 7 | 450 | |
| H Ikegami | 87 | 350 | 193 | 265 | 8 | 401 | |
| Adrie Gunther | 44 | 98 | 173 | 135 | 4 | 393 | |
| A. Degen | 54 | 247 | 99 | 190 | 9 | 436 | |
| Kyung Ryoul Kim | 17 | 149 | 190 | 147 | 8 | 429 | |
| Juan Esquivel | 51 | 70 | 279 | 219 | 7 | 449 |
All Works
Loading papers...